OPKO Health

OPKO Health

Developing proprietary versions of proteins already approved for medical therapy.

HQ location
Miami, United States
Website
opko.com
Launch date
Employees
1001-5000 people
Market cap
$1.1b
Enterprise value
$1.1b
Share price
$1.32 OPK
Jobs
View job openings
Recent deals
http://www.facebook.com/pages/OPKO-Health/303947936433551https://www.linkedin.com/company/opko-health-inc.
    • Edit
loading funding rounds…
BioAdvance
BioAdvance(exited)
HealthCare Royalty
HealthCare Royalty

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2021202220232024202520262027
Revenues0000000000000000000000000000
% growth24 %(43 %)(14 %)(17 %)(9 %)8 %14 %
EBITDA0000000000000000000000000000
% EBITDA margin-(18 %)(8 %)6 %(12 %)(2 %)11 %
Profit0000000000000000000000000000
% profit margin(2 %)(33 %)(22 %)(7 %)(37 %)(22 %)(12 %)
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue4 %7 %10 %15 %---

Source: Company filings or news article, Equity research estimates

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by OPKO Health

Edit
Fabrus
Fabrus
Phio Pharmaceuticals
Phio Pharmaceuticals
exited
Claros Diagnostics
Claros Diagnostics
ACQUISITION by OPKO Health Oct 2011
PROLOR Biotech
PROLOR Biotech
ACQUISITION by OPKO Health Aug 2013
Transition Therapeutics
Transition Therapeutics
ACQUISITION by OPKO Health Jun 2016
Arno Therapeutics
Arno Therapeutics
exited
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals
ACQUISITION by Sevion Therapeutics Jun 2017
Healthsnap
Healthsnap
ModeX Therapeutics
ModeX Therapeutics
ACQUISITION by OPKO Health May 2022